Hedge Fund Veteran Doug Kass Says Most Cannabis Stocks Are 'Walking Dead,' But These 4 Names Stand Out Doug Kass says most cannabis stocks are ‘walking dead' — but highlights Trulieve, GTI, TerrAscend and Glass House as top picks for patient investors.
This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward This week: Q1 earnings reveal a widening market divide, DEA nominee prioritizes rescheduling, and Rove and Swade make big expansion plays.
Trulieve Q1 Earnings: Revenue, EPS Beat Estimates On 'Strong' Margins, Cash Flow Trulieve reported first-quarter revenue of $297.8 million, beating analyst estimates of $294.4 million, according to Benzinga Pro. The cannabis company reported a first-quarter adjusted loss of 2 cents per share, beating estimates for a loss of 8 cents per share.
DeSantis Signs New Petition Law That Could Block Marijuana Ballot Campaign—Lawsuit Challenges Constitutionality Florida's new ballot law targets cannabis legalization efforts and sparks a federal lawsuit. Major backers include Trulieve, Verano, Curaleaf.
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp' Cannabis stocks jumped as Trump reportedly pushes SAFE Banking behind the scenes—but analysts warn: don't chase the hype just yet.
